Development of (89)Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications

PURPOSE: The complexity of sarcoma has led to the need for patient selection via in vivo biomarkers. Tumor endothelial marker-1 (TEM-1) is a cell surface marker expressed by the tumor microenvironment. Currently MORAb-004 (Ontuxizumab), an anti-TEM-1 humanized monoclonal antibody, is in sarcoma clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lange, Sara E.S., Zheleznyak, Alex, Studer, Matthew, O'Shannessy, Daniel J., Lapi, Suzanne E., Van Tine, Brian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914343/
https://www.ncbi.nlm.nih.gov/pubmed/26909615
http://dx.doi.org/10.18632/oncotarget.7552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914343/
https://www.ncbi.nlm.nih.gov/pubmed/26909615
http://dx.doi.org/10.18632/oncotarget.7552

Ejemplares similares